Promoting adherence and increasing life Span

Research output: Contribution to journalArticle

Abstract

For patients with cystic fibrosis, adherence with lifelong treatment may be challenging, particularly as individuals enter into emerging adulthood (age 19-25 years). This article explores the various factors that are known to impact adherence, with a focus on the contribution of emerging adulthood on the major nonadherence typologies (erratic adherence, unwitting nonadherence, and intelligent nonadherence). Social support is considered critical to adherence, with practical support (eg, instrumental support, assistance, reminders, and organization), emotional support (eg, nurturance and empathy), and having a cohesive family all highly associated with treatment compliance. Patients who fall into one of the nonadherence typologies have a general higher risk of nonadherence as they enter adulthood because a major aspect of social support (parental involvement) begins to diminish. For example, patients with erratic adherence (understand andagree with therapy but have difficulty consistently maintaining regimens) may find it particularly difficult to adhere to regimens during emerging adulthood, in the face of variable college and sleeping schedules, work schedules, travel, alcohol consumption, and impromptu social opportunities. Also discussed in this article are reliable ways of measuring adherence (medication refill history and patient reports of nonadherence) and empirically supported adherence promotion techniques.

Original languageEnglish (US)
Pages (from-to)14-19
Number of pages6
JournalAdvanced Studies in Medicine
Volume9
Issue number1
StatePublished - Mar 2009

Fingerprint

Social Support
Appointments and Schedules
Medication Adherence
Patient Compliance
Cystic Fibrosis
Alcohol Drinking
Therapeutics
History
Organizations

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Promoting adherence and increasing life Span. / Riekert, Kristin.

In: Advanced Studies in Medicine, Vol. 9, No. 1, 03.2009, p. 14-19.

Research output: Contribution to journalArticle

@article{1cfeb58777844bfb97d978434793dba3,
title = "Promoting adherence and increasing life Span",
abstract = "For patients with cystic fibrosis, adherence with lifelong treatment may be challenging, particularly as individuals enter into emerging adulthood (age 19-25 years). This article explores the various factors that are known to impact adherence, with a focus on the contribution of emerging adulthood on the major nonadherence typologies (erratic adherence, unwitting nonadherence, and intelligent nonadherence). Social support is considered critical to adherence, with practical support (eg, instrumental support, assistance, reminders, and organization), emotional support (eg, nurturance and empathy), and having a cohesive family all highly associated with treatment compliance. Patients who fall into one of the nonadherence typologies have a general higher risk of nonadherence as they enter adulthood because a major aspect of social support (parental involvement) begins to diminish. For example, patients with erratic adherence (understand andagree with therapy but have difficulty consistently maintaining regimens) may find it particularly difficult to adhere to regimens during emerging adulthood, in the face of variable college and sleeping schedules, work schedules, travel, alcohol consumption, and impromptu social opportunities. Also discussed in this article are reliable ways of measuring adherence (medication refill history and patient reports of nonadherence) and empirically supported adherence promotion techniques.",
author = "Kristin Riekert",
year = "2009",
month = "3",
language = "English (US)",
volume = "9",
pages = "14--19",
journal = "Advanced Studies in Medicine",
issn = "1530-3004",
publisher = "Galen Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Promoting adherence and increasing life Span

AU - Riekert, Kristin

PY - 2009/3

Y1 - 2009/3

N2 - For patients with cystic fibrosis, adherence with lifelong treatment may be challenging, particularly as individuals enter into emerging adulthood (age 19-25 years). This article explores the various factors that are known to impact adherence, with a focus on the contribution of emerging adulthood on the major nonadherence typologies (erratic adherence, unwitting nonadherence, and intelligent nonadherence). Social support is considered critical to adherence, with practical support (eg, instrumental support, assistance, reminders, and organization), emotional support (eg, nurturance and empathy), and having a cohesive family all highly associated with treatment compliance. Patients who fall into one of the nonadherence typologies have a general higher risk of nonadherence as they enter adulthood because a major aspect of social support (parental involvement) begins to diminish. For example, patients with erratic adherence (understand andagree with therapy but have difficulty consistently maintaining regimens) may find it particularly difficult to adhere to regimens during emerging adulthood, in the face of variable college and sleeping schedules, work schedules, travel, alcohol consumption, and impromptu social opportunities. Also discussed in this article are reliable ways of measuring adherence (medication refill history and patient reports of nonadherence) and empirically supported adherence promotion techniques.

AB - For patients with cystic fibrosis, adherence with lifelong treatment may be challenging, particularly as individuals enter into emerging adulthood (age 19-25 years). This article explores the various factors that are known to impact adherence, with a focus on the contribution of emerging adulthood on the major nonadherence typologies (erratic adherence, unwitting nonadherence, and intelligent nonadherence). Social support is considered critical to adherence, with practical support (eg, instrumental support, assistance, reminders, and organization), emotional support (eg, nurturance and empathy), and having a cohesive family all highly associated with treatment compliance. Patients who fall into one of the nonadherence typologies have a general higher risk of nonadherence as they enter adulthood because a major aspect of social support (parental involvement) begins to diminish. For example, patients with erratic adherence (understand andagree with therapy but have difficulty consistently maintaining regimens) may find it particularly difficult to adhere to regimens during emerging adulthood, in the face of variable college and sleeping schedules, work schedules, travel, alcohol consumption, and impromptu social opportunities. Also discussed in this article are reliable ways of measuring adherence (medication refill history and patient reports of nonadherence) and empirically supported adherence promotion techniques.

UR - http://www.scopus.com/inward/record.url?scp=77953466438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953466438&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:77953466438

VL - 9

SP - 14

EP - 19

JO - Advanced Studies in Medicine

JF - Advanced Studies in Medicine

SN - 1530-3004

IS - 1

ER -